Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials

Patoulias, Dimitrios; Popovic, Djordje S; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi

Results

eNauka > Results > Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials

Title:	Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
Authors:	Patoulias, Dimitrios; Popovic, Djordje S ; Pantea-Stoian, Anca; Janez, Andrej; Sahebkar, Amirhossein; Rizzo, Manfredi
Issue Date:	2023
Publication:	JOURNAL OF DIABETES AND ITS COMPLICATIONS
ISSN:	1056-8727 Journal of Diabetes and Its Complications Search Idenfier
Type:	Article
Collation:	vol. 37 br. 8 str. Art. No 108529
DOI:	10.1016/j.jdiacomp.2023.108529
WoS-ID:	001021247400001
Scopus-ID:	2-s2.0-85161264809
PMID:	37301063
URI:	https://enauka.gov.rs/handle/123456789/811152
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	23M23

2
SCOPUS^TM

1
PubMed Central^TM

2
WEB OF SCIENCE^TM

Altmetric

Dimensions

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Unpaywall